Insider Selling: Outset Medical, Inc. (NASDAQ:OM) CFO Sells $27,430.40 in Stock

Outset Medical, Inc. (NASDAQ:OM) CFO Nabeel Ahmed sold 34,288 shares of the stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $0.80, for a total value of $27,430.40. Following the completion of the sale, the chief financial officer now owns 258,869 shares of the company’s stock, valued at approximately $207,095.20. This represents a 11.70 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Nabeel Ahmed also recently made the following trade(s):

• On Monday, January 13th, Nabeel Ahmed sold 29,031 shares of Outset Medical stock. The stock was sold at an average price of $0.81, for a total value of $23,515.11.
• On Tuesday, January 7th, Nabeel Ahmed sold 1,835 shares of Outset Medical stock. The stock was sold at an average price of $1.29, for a total value of $2,367.15.
• On Friday, November 15th, Nabeel Ahmed sold 4,221 shares of Outset Medical stock. The shares were sold at an average price of $0.80, for a total transaction of $3,376.80.

Outset Medical Stock Performance

Shares of NASDAQ OM opened at $0.85 on Friday. The business has a 50 day moving average price of $1.01 and a two-hundred day moving average price of $1.26. Outset Medical, Inc. has a fifty-two week low of $0.44 and a fifty-two week high of $5.22. The company has a debt-to-equity ratio of 4.12, a quick ratio of 5.04 and a current ratio of 6.49.

Institutional Trading of Outset Medical

A number of hedge funds have recently made changes to their positions in the stock. Vanguard Personalized Indexing Management LLC bought a new stake in Outset Medical in the second quarter valued at about $49,000. Huntington National Bank increased its holdings in shares of Outset Medical by 46.2% in the 3rd quarter. Huntington National Bank now owns 63,306 shares of the company’s stock valued at $43,000 after acquiring an additional 20,000 shares during the last quarter. National Bank of Canada FI raised its position in shares of Outset Medical by 79.2% during the 3rd quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock valued at $35,000 after acquiring an additional 23,164 shares in the last quarter. Squarepoint Ops LLC lifted its stake in Outset Medical by 74.1% during the second quarter. Squarepoint Ops LLC now owns 80,300 shares of the company’s stock worth $309,000 after purchasing an additional 34,187 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new position in Outset Medical in the second quarter worth $259,000.

Analysts Set New Price Targets

Separately, Royal Bank of Canada restated a “sector perform” rating and issued a $3.00 target price on shares of Outset Medical in a research note on Tuesday, January 7th.

Outset Medical Company Profile

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.